Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, 2014. ,
New biomarkers and targets in pancreatic cancer and their application to treatment, Nat Rev Gastroenterol Hepatol, 2012. ,
Stromal biology and therapy in pancreatic cancer, Gut, 2011. ,
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma, Cancer Cell, 2012. ,
Strategies to relieve immunosuppression in pancreatic cancer, Immunotherapy, 2015. ,
T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma, Cancer Cell, 2015. ,
Coordinated regulation of myeloid cells by tumours, Nat Rev Immunol, vol.12, pp.253-68, 2012. ,
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards, Nat Commun, vol.7, p.12150, 2016. ,
Myeloid-derived suppressor cells: immunesuppressive cells that impair antitumor immunity and are sculpted by their environment, J Immunol, vol.200, pp.422-453, 2018. ,
Tumorderived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer, Cancer Cell, 2012. ,
Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia, Cancer Cell, 2012. ,
Dynamics of the immune reaction to pancreatic cancer from inception to invasion, Cancer Res, 2007. ,
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity, Gut, vol.63, pp.1769-81, 2014. ,
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy, Cancer Immunol Immunother, 2011. ,
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13, Cancer Immunol Immunother, 2011. ,
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloidderived suppressor cells which promote primary tumor growth, Cancer Immunol Immunother, 2012. ,
Suppression, subversion and escape: the role of regulatory T cells in cancer progression, Clin Exp Immunol, 2013. ,
Regulatory T cells in cancer immunotherapy, Curr Opin Immunol, vol.27, pp.1-7, 2014. ,
New strategies for cancer immunotherapy: targeting regulatory T cells, Genome Med, 2017. ,
Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma, Oncogene, vol.36, pp.3048-58, 2017. ,
Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer, J Immunol, 2009. ,
Pancreatic ductal adenocarcinoma: a review of immunologic aspects, J Investig Med, 2012. ,
Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas, J Invest Dermatol, vol.132, pp.1239-1285, 2012. ,
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells, Cancer Res, vol.68, pp.5439-5488, 2008. ,
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth, J Immunol, 2012. ,
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF?-induced differentiation of CD4 + CD25 + FoxP3 + Tregs from CD4 + CD25-FoxP3-T cells, J Leukoc Biol, vol.92, pp.987-97, 2012. ,
Bioluminescent orthotopic model of pancreatic cancer progression, J Vis Exp, vol.50395 ,
CD103 is a hallmark of tumor-infiltrating regulatory T cells, Int J Cancer, 2011. ,
Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner, Cell Rep, 2015. ,
Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy, Hum Vaccin Immunother, 2014. ,
Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer, J Immunother Cancer, 2010. ,
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1 + CD11b + myeloid cells, Cancer Res, vol.66, pp.6807-6822, 2006. ,